Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

Explore the role of transcription factor biology in drug discovery and how it impacts our understanding of disease mechanisms ...

Rare diseases are genetic disorders that affect a small proportion of the population. Despite their rarity, they can be a ...

Illumina is building the most comprehensive multiomic solutions in the industry, anchored on its world-class sequencing platforms for unmatched quality and scale. For research and pharma innovators, ...

A groundbreaking review in Biological Diversity proposes a proactive, AI - integrated approach to stop biological invasions ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

The molecular understanding of brain tumors has undergone a profound transformation in recent years. Advances in genomics, ...

Biological invasion has become one of the most significant drivers of global ecological disruption, causing billions of dollars in ...

Mitochondrial respiratory complexes (Complexes I–V) and their assembly into respiratory supercomplexes (SCs) are fundamental to liver bioenergetics, redox homeostasis, and metabolic adaptability.

The future of clinical development hinges on viewing biological systems holistically. By integrating diverse molecular data ...